Where Will Recursion Pharmaceuticals Be in 5 Years?

If it can bounce back and generate solid returns in the next five years, now is about as good a time as any to invest in the ...
Seeking Alpha

Recursion Pharmaceuticals: Catalysts Are Coming And Success Is A Must

Recursion Pharma is an AI-driven drug developer that boasts supercomputers designed to shorten drug development timelines and enhance successful outcomes. Many such companies have raised substantial ...
KTLA

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides ...

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...